MFN2 and Alzheimer disease: However, in AD, Drp-1 marker levels increased (p = 0.0003) and Opa-1 levels decreased (p = 0.0115), while Mfn-2 marker levels remained unchanged (p ≤ 0.0001) (Figure 3J–L).